Portal:Disease/COVIDPathways
From WikiPathways
| Line 41: | Line 41: | ||
|} | |} | ||
{| style="margin: 10px; background-color:#AFDCDE" | {| style="margin: 10px; background-color:#AFDCDE" | ||
| - | |width=100px|{{#pwImage:Pathway: | + | |width=100px|{{#pwImage:Pathway:WP4891|250px||COVID-19 AOP}} |
Experimental pathway to investigate overlap of virus-host interaction and adverse outcome pathways | Experimental pathway to investigate overlap of virus-host interaction and adverse outcome pathways | ||
|- | |- | ||
Revision as of 13:31, 7 April 2020
|
This special subset of disease pathways is being highlighted during the current COVID-19 crisis. This content is released under a CC0 waiver to be freely used, reused and distributed. Let us know if you add a new pathway or want to recommend one for this collection. |
|
Image does not exist SARS-CoV-2 and COVID-19 Pathway Collaborative project for curation biological processes involved in the COVID-19 disease after SARS-Cov-2 infection. |
Image does not exist Coronavirus lipid metabolism Lipid metabolism alternations that are related to infection by the corona virus. |
Image does not exist Hijack of Ubiquitination by SARS-CoV-2 SARS-CoV-2 includes a novel Orf10 that interacts with muliple members of the Cullin 2 ubiquitin ligase complex. |
Image does not exist Autophagy during CoV infection |
|
Image does not exist Integrative stress response in SARS-CoV-2 infection |
Image does not exist Host-pathogen interaction of human corona viruses - autophagy |
Image does not exist Host-pathogen interaction of human corona viruses - apoptosis |
Image does not exist Type I Interferon Induction and Signaling During SARS-CoV-2 Infection The induction and signaling of type I interferon with specific SARS-CoV-2 protein and relevant drug. |
|
Image does not exist Host-pathogen interaction of human corona viruses - ER stress |
Image does not exist Downregulation of ACE2 expression by SARS-CoV infection and SARS-CoV Spike protein |
Image does not exist Activation of NLRP3 Inflammasome by SARS-CoV-2 Orf3a from SARS-CoV has been shown to bind TRAF3 and activate the NLRP3 inflammasome. |
Image does not exist Host-pathogen interaction of human corona viruses - MAPK signaling |
|
Image does not exist Host-pathogen interaction of human corona viruses - Interferon induction |
Image does not exist SARS-CoV-2 and Angiotensin-converting enzyme 2 (ACE2) receptor : Molecular mechanisms and potential therapeutic target |
Image does not exist The interferon-MAPK pathway in response to SARS-CoV-2 infection The interferon-MAPK pathway in response to SARS-CoV-2 infection. |
Image does not exist nsp9/nsp10-mediated SARS-CoV-2 pathogenesis Virus-host interactome and proteomic survey of PMBCs from COVID-19 patients reveal potential virulence factors influencing SARS-CoV-2 pathogenesis |
|
Image does not exist COVID-19 AOP Experimental pathway to investigate overlap of virus-host interaction and adverse outcome pathways |
More about ACE2
|
Image does not exist ACE Inhibitor Pathway |
Image does not exist Metabolism of Angiotensinogen to Angiotensins (Reactome) |
